Pemvidutide: Trial Shows Promising Results for Fatty Liver Disease |
Clinical News
eMediNexus Coverage from: 
Pemvidutide: Trial Shows Promising Results for Fatty Liver Disease

0 Read Comments                

A new study presented at the annual International Liver Congress, sponsored by the European Association for the Study of the Liver, showed that weight loss, lipid reductions, and "robust improvements" in lipid species associated with non-alcoholic fatty liver disease were achieved in patients who were treated with pemvidutide in a first-in-human, phase 1 clinical trial. The phase 1 study results presented by Stephen A Harrison, MD, showed that in a randomized, double-blind, placebo-controll...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now